https://www.selleckchem.com/pr....oducts/bemnifosbuvir
Elderly patients are the fastest growing population requiring renal replacement therapy. As previous studies have shown a survival benefit of kidney transplantation compared to dialysis for end-stage renal disease, we sought to evaluate if this survival benefit extends to octogenarians. This was a single-center retrospective cohort study of renal allograft recipients ≥80years transplanted from 1999 to 2014 who were compared to patients listed during the same period that did not proceed to transplantation. A seco
Like
Comment
Share
